API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. AU /
  3. PAR.AU

Paradigm Biopharmaceuticals Ltd (PAR AU) stock market data APIs

A$0.24 0.02(9.1%) as of September 20, 2024
Price chart is built with Anychart

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

Paradigm Biopharmaceuticals Ltd Financial Data Overview

0.22
0.24
-
0.24
0.22
0.21-0.78
84 087 K
350 M
42 050
0.941
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PAR',
Type: 'Common Stock',
Name: 'Paradigm Biopharmaceuticals Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG009QNWX21',
ISIN: 'AU000000PAR5',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Paradigm Biopharmaceuticals Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 42 050
  • EBITDA -64 965 448
  • Earnings Per Share -0.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Paradigm Biopharmaceuticals Ltd Earnings via APIs

  • Latest Release 2024-08-30
  • EPS/Forecast NaN

Get Paradigm Biopharmaceuticals Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Paradigm Biopharmaceuticals Ltd latest news via APIs

Hope for knee osteoarthritis sufferers with advent of global clinical trial.

Paradigm Biopharma launches clinical trial website to support development program for knee osteoarthritis therapy. MELBOURNE, Australia, May 25, 2023 /PRNewswire/ -- With the launch of a new website ...

Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up

Paradigm Biopharmaceuticals Top-line phase 2 trial data shows disease modifying potential and pain reduction MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharma...
Do you have any questions?
support@eodhistoricaldata.com